Top Marine Biotechnology Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Marine Biotechnology Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Marine Biotechnology industry players.

Marine Biotechnology Market Competitive Landscape

Global Marine Biotechnology Market is highly competitive, with a number of key players operating in the market. Some of the major players in the market are focusing on various strategies such as partnerships, collaborations, mergers and acquisitions, and new product launches to gain a competitive edge in the market. For instance, in February 2021, Lonza Group Ltd. acquired HansaBioMed Life Sciences Ltd. to expand its capabilities in the development and production of biological therapeutics. Moreover, several research institutions and universities are also actively involved in marine biotechnology research and development, leading to the creation of new companies and startups in the market. The growing number of research activities in the field is expected to drive innovation and competitiveness in the market.

Top Player’s Company Profiles in Marine Biotechnology Market

  • BASF SE (Germany)
  • CP Kelco (US)
  • Cyanotech Corporation (US)
  • DowDuPont Inc. (US)
  • FMC Corporation (US)
  • Lonza Group AG (Switzerland)
  • Marinova Pty Ltd (Australia)
  • New England Biolabs Inc. (US)
  • Novozymes A/S (Denmark)
  • PML Applications Ltd (UK)
  • PharmaMar S.A. (Spain)
  • Seppic (France)
  • Solutex GC (Spain)
  • Sonneborn LLC (US)
  • The Lubrizol Corporation (US)
  • The Scottish Association for Marine Science (UK)
  • Thermo Fisher Scientific Inc. (US)
  • Tiger Brands Limited (South Africa)
  • Unilever NV (Netherlands)
  • Xiamen Kingdomway Group Co. Ltd. (China)

Marine Biotechnology Market

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Marine Biotechnology Market size was valued at USD 6.95 Billion in 2024 and is poised to grow from USD 7.43 Billion in 2025 to USD 12.67 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033). 

Global Marine Biotechnology Market is highly competitive, with a number of key players operating in the market. Some of the major players in the market are focusing on various strategies such as partnerships, collaborations, mergers and acquisitions, and new product launches to gain a competitive edge in the market. For instance, in February 2021, Lonza Group Ltd. acquired HansaBioMed Life Sciences Ltd. to expand its capabilities in the development and production of biological therapeutics. Moreover, several research institutions and universities are also actively involved in marine biotechnology research and development, leading to the creation of new companies and startups in the market. The growing number of research activities in the field is expected to drive innovation and competitiveness in the market. 'BASF (Germany) ', 'Cyanotech Corp. (USA) ', 'Kerry Group (Ireland) ', 'Corbion (Netherlands) ', 'FMC Corp. (USA) ', 'Marine Biotech (USA) ', 'Royal DSM (Netherlands) ', 'TransGen Biotech Co., Ltd. (China) ', 'Olmix Group (France) ', 'Ittinsect (Italy) ', 'BRAIN Biotech AG (Germany) ', 'Biotech Marine (France) ', 'Marinova Pty Ltd (Australia) ', 'Pharma Mar, S.A. (Spain) ', 'GlycoMar Ltd. (UK) ', 'Aker BioMarine ASA (Norway) ', 'oceanBASIS GmbH (Germany) ', 'Primex Iceland (Iceland) ', 'New England Biolabs (NEB) (USA) '

With the increasing awareness of environmental concerns and sustainability, there is a growing demand for eco-friendly products across various industries. Marine biotechnology offers a range of sustainable and eco-friendly solutions, such as marine-derived enzymes for industrial applications, biofuels, and bioplastics. For instance, a company called Algix produces bioplastic materials from algae, which are biodegradable and sustainable alternatives to traditional plastic materials.

Marine Biomaterials - The use of marine-derived biomaterials is an emerging trend in the marine biotechnology market, with numerous potential applications in the fields of medicine, tissue engineering, and regenerative medicine. For instance, marine collagen has been shown to have superior properties compared to mammalian collagen and is being explored as a potential biomaterial for use in wound healing and tissue regeneration.

North America dominated the global marine biotechnology market, owing to its well-developed infrastructure and favorable government initiatives to promote the use of marine resources in biotechnology research. The United States is the largest market in this region, with a significant number of marine biotechnology companies and research organizations.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Marine Biotechnology Market
Marine Biotechnology Market

Report ID: SQMIG35H2077

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE